Updates on Patent Foramen Ovale (PFO) Closure
- 24 June 2024
- journal article
- review article
- Published by Springer Nature in Current Cardiology Reports
- Vol. 26 (7) , 735-746
Abstract
Purpose of Review Patent foramen ovale (PFO) has been previously linked to left circulation thromboembolism and stroke. This review article aims to discuss the latest evidence, updated societal guidelines, diagnostic algorithms and novel therapeutic devices for PFO closure. Recent Findings PFO closure for cryptogenic stroke and systemic embolization is supported by a large body of evidence and has a strong societal recommendation. Limited data are available for platypnea-orthodeoxia syndrome, although closure appears to be beneficial. Current data do not support routine closure for migraines and decompression Illness. Development of heart-brain teams can improve identification of patients most likely to benefit from closure, utilizing a combination of imaging test and risk score algorithms. Multiple novel devices aiming at reducing complications and improving the long-term impact of current available devices are being evaluated. Summary PFO closure has significantly progressed over the last years, with new data supporting its superiority in reducing risk of recurrent embolic stroke in patients with PFO-related stroke. Additional clinical data are required to provide further refinements on patient selection and guidance on treatment of specific subgroups.Keywords
This publication has 70 references indexed in Scilit:
- Comparative evaluation of intracardiac, transesophageal, and transthoracic echocardiography in the assessment of patent foramen ovale: A retrospective single‐center studyCatheterization and Cardiovascular Interventions, 2023
- New-onset atrial fibrillation after percutaneous patent foramen ovale closure: a meta-analysisClinical Research in Cardiology, 2023
- Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After StrokeJAMA, 2021
- Use of the NobleStitch™ EL for the treatment of patients with residual right‐to‐left shunt following device closure of PFOClinical Case Reports, 2021
- SCAI expert consensus statement on operator and institutional requirements for PFO closure for secondary prevention of paradoxical embolic strokeCatheterization and Cardiovascular Interventions, 2019
- Percutaneous transcatheter closure of high-risk patent foramen ovale in the elderlyHeart and Vessels, 2019
- Percutaneous patent foramen ovale closure using the Occlutech Figulla device: More than 1,300 patient‐years of follow upCatheterization and Cardiovascular Interventions, 2018
- A randomized, controlled, multi‐center trial of the efficacy and safety of the Occlutech Figulla Flex‐II Occluder compared to the Amplatzer Septal Occluder for transcatheter closure of secundum atrial septal defectsCatheterization and Cardiovascular Interventions, 2018
- The effect of patent foramen ovale closure in patients with platypnea‐orthodeoxia syndromeCatheterization and Cardiovascular Interventions, 2015
- Platypnea-orthodeoxia syndrome: Etiology, differential diagnosis, and managementCatheterization and Cardiovascular Interventions, 1999